Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Par reorganizes, drops 190 employees
Par Pharmaceutical will cut 190 jobs--more than a fourth of its workforce--in an effort to contain costs over the next year. Sixty of the 190 workers will see pink slips before they ring in the new year; the rest will be gone by mid- 2009.
Par's chief operating officer will be leaving the company as well.
The 20-year-old company will focus on its most profitable products and "align the company's cost structure with the size of its operations and development pipeline," according to the CEO, Pat LePor. Par execs believe the company's restructuring efforts will result in annual savings of up to $55 million.
- read the story at LoHud.com
- find the Pharmalot blog post
Be the first to comment
More stories about Par Pharmaceuticals
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
